MWN Medical Minutes: April 13, 2023

FDA Approves First Naloxone Product for Over-the-Counter Use | Millennials, Gen Xers Increase Risk of Nonmelanoma Skin Cancer | Opioid Manufacturers Required to Provide Mail-Back Envelopes to Accompany Prescriptions